Efficacy of a wearable biosensor for patients with COVID-19 or cardiopulmonary diseases
Not Applicable
- Conditions
- i) SARS-CoV-2 PCR positive COVID-19 patient ii) Heart failure iii) Sleep apnea syndrome iv) Asthma v) Chronic obstructive pulmonary disease vi) Intestinal pneumonia vii) Pulmonary mycobacterium avium complex disease viii) Pediatric inguinal hernia ix) Congenital cystic disease of lung x) Pediatric metastatic lung tumors xi) Pneumonia
- Registration Number
- JPRN-UMIN000043546
- Lead Sponsor
- Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Cannot use a developed medical device 2) Cannot obtain a written informed consent because of severe medical conditions (e.g. intubated) 3) Principle investigators considered inappropriate for eligibility 4) Pneumonia patients with A-DROP score equal or more than 3
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulse rate and SpO2
- Secondary Outcome Measures
Name Time Method